David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Where Will Microsoft (MSFT) Stock Be in 5 Years?

By David Moadel, InvestorPlace Contributor

For outstanding long-term, dividend-enhanced returns, a "slow and steady wins the race" strategy is ideal for MSFT stock.

SQ Stock Alert: Block Rises on a Big CashApp Boost

By David Moadel, InvestorPlace Contributor

People curtailed their spending in Q3 - or did they? They used the Cash App vigorously, and SQ stock traders are celebrating a strong quarter.

Where Will Meta Materials (MMAT) Stock Be in 5 Years?

By David Moadel, InvestorPlace Contributor

Even as Meta Materials has plenty of purchase orders coming in, MMAT stock looks underappreciated and poised for a multi-year run-up.

COP Stock Alert: 3 Major Takeaways From ConocoPhillips’ Q3 Earnings

By David Moadel, InvestorPlace Contributor

COP stock has not just one, but multiple positive catalysts today as ConocoPhillips' investors pore over the energy firm's Q3 results.

Why Is Virax (VRAX) Stock Up 40% Today?

By David Moadel, InvestorPlace Contributor

VRAX stock is powering higher as Virax Biolabs launches a test kit that addresses not just one, but three separate diseases.

This Politician Just Bought a Chunk of TSLA Stock. Should You?

By David Moadel, InvestorPlace Contributor

Is there government support for TSLA stock or not? As a House member takes a stake but two agencies probe Tesla, tough questions remain.

Chegg (CHGG) Stock Soars on Strong Earnings Beat

By David Moadel, InvestorPlace Contributor

CHGG stock is enjoying strong gains after the company reported Q3 earnings that beat Wall Street's estimates.

Why Investors Should Bet $100 on GameStop (GME) Stock

By David Moadel, InvestorPlace Contributor

If there's one thing the short-selling hedge funds should know by now, it's that the diamond hands could win the trading war over GME stock.

Why Is Arcturus Therapeutics (ARCT) Stock Up 30% Today?

By David Moadel, InvestorPlace Contributor

The run-up in ARCT stock is practically unstoppable as two science-focused firms collaborate to develop mRNA technology.

5 Investors Betting Big on AMD Stock. Should You?

By David Moadel, InvestorPlace Contributor

Some famous names in the world of finance have positioned themselves for AMD stock's potential post-earnings upside.

Load More